A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell lung cancer and brain metastases, finding they ...

Targeted radiation therapy might be a safer way to treat a potentially dangerous heart rate problem, a new study says. Radiation therapy treated ventricular tachycardia as well as a standard but ...

Radiation therapy advancements, including SBRT and proton therapy, have improved precision and reduced side effects for GI cancer patients, enhancing their quality of life. Personalized treatment ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

Targeted radiation-based therapies for treating cancerous tumours such as 'boron neutron capture therapy' (BNCT), rely on the efficient and effective delivery of the capture agent (in this case, boron ...

In oncology, few diagnoses carry the weight of pancreatic ductal adenocarcinoma. Long characterized by its aggressive nature and silent progression, pancreatic cancer remains one of the most ...

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...